Fabrazyme
Links shared publicly online about this topic
European Medicines Agency Reviews Treatment Recommendations For Fabrazyme
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has reviewed its previous recommendations on the use of Fabrazyme (agalsidase beta) during the ongoing supply” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2010 at 1:05 pm By:
MNT Drug Approvals Health News
European Medicines Agency Reviews Treatment Recommendations For Fabrazyme http://mnt.to/3LDS #regulatory
Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot
pharmalot.com — “Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on August 5, 2011 at 1:50 am By:
Stéphane Potdevin Health Social Media, Health Marketing, and Pharma
RT @pharmalot: Genzyme Angers Patients Over Fabrazyme Supplies http://bit.ly/pGBG0O #genzyme #yam
Fabrazyme Shortage Killed My Husband: Widow // Pharmalot
pharmalot.com — “Fabrazyme Shortage Killed My Husband: Widow // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on March 9, 2012 at 2:21 pm By:
Fabrazyme Shortage Killed My Husband: Widow... Death by Drug Shortage? http://t.co/O4WX2bvi #pharma #drugshortages
Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot
pharmalot.com — “Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on August 5, 2011 at 11:26 am By:
Genzyme's Fabrazyme supplies disrupted again. Guess Sanofi's finding it harder to fix production issues than expected. http://bit.ly/nPHsiD
Pharmacy Europe - EMA reviews treatment recommendations for Fabrazyme
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on October 24, 2010 at 4:12 am By:
Drugs and Devices OW OW Health
EMA reviews treatment recommendations for Fabrazyme: The EMA's Committee for Medicinal Products for Human Use (CHM... http://bit.ly/9C62QD
Patients suffer as drug maker rations Fabrazyme medicine
post-gazette.com — “Patients suffer as drug maker rations Fabrazyme medicine” View full resource at post-gazette.com
Most Recently Shared on July 11, 2011 at 2:39 am By:
Drug for Fabry disease being rationed in US, while company turns a huge profit through European deal. THIS IS NOT... http://fb.me/MbISyQQn
European Medicines Agency Updates Treatment Recommendations Because Of Continued Fabrazyme Shortage
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has been obliged to revise its previous recommendations on the use of Fabrazyme (agalsidase beta). This follow” View full resource at medicalnewstoday.com
Most Recently Shared on July 7, 2010 at 10:29 am By:
Urology & Nephrology OW Health
European Medicines Agency Updates Treatment Recommendations Because Of Continued Fabrazyme Shortage: The European ... http://mnt.to/f/3FMf
More supply woes as Genzyme scraps Fabrazyme batch - FiercePharma
fiercepharma.com — “Yet another problem at its Allston Landing, MA, plant has disrupted Genzyme's Fabrazyme supply and prompted a re-think of its manufacturing efforts. The news is sure to disappoint Fabry disease... Read more...” View full resource at fiercepharma.com
Most Recently Shared on March 24, 2011 at 1:21 pm By:
More supply woes as Genzyme scraps Fabrazyme batch. http://bit.ly/fSvxb5
Spoonful of Medicine: Patient groups cautiously optimistic about Fabrazyme plant approval
blogs.nature.com — “Two-and-a-half years after a virus struck Genzyme’s main production plant—triggering worldwide shortages of Fabrazyme, an enzyme replacement therapy for Fabry’s disease, an illness that afflicts fewer than 10,000 people worldwide—regulators in the US and EU have approved a new manufacturing facility. With the opening of the new plant, Genzyme announced today that all Americans currently taking Fabrazyme (agalsidase beta) and the most severely affected European patients should be up to full dosin” View full resource at blogs.nature.com
Most Recently Shared on January 24, 2012 at 8:58 pm By:
Nature Medicine Science Enthusiast
Patient groups cautiously optimistic about Fabrazyme plant approval: http://t.co/DqbGBJ9G
Genzyme's Fabrazyme Should Be Given in Full Dose, EU Says - Bloomberg
bloomberg.com — “Genzyme Corp.'s Fabrazyme drug for Fabry disease should be given in a full dose after patients receiving a lesser amount reported side effects, the European Medicines Agency said in an e-mailed statement. Patients also can be given a full dose of Shire Plc's Replagal, the agency said.” View full resource at bloomberg.com
Most Recently Shared on October 22, 2010 at 11:20 am By:
Bloomberg: Genzyme’s Fabrazyme Should Be Given in Full Dose, EU Says. http://bit.ly/dawfCu
Spoonful of Medicine: Patient groups cautiously optimistic about Fabrazyme plant approval
blogs.nature.com — “Two-and-a-half years after a virus struck Genzyme’s main production plant—triggering worldwide shortages of Fabrazyme, an enzyme replacement therapy for Fabry’s disease, an illness that afflicts fewer than 10,000 people worldwide—regulators in the US and EU have approved a new manufacturing facility. With the opening of the new plant, Genzyme announced today that all Americans currently taking Fabrazyme (agalsidase beta) and the most severely affected European patients should be up to full dosin” View full resource at blogs.nature.com
Most Recently Shared on January 25, 2012 at 10:02 pm By:
Nature Medicine Science Enthusiast
Patient groups cautiously optimistic about Fabrazyme plant approval http://t.co/Iy8cj2mP
Genzyme Begins Shipping Fabrazyme from Newly Approved Framingham Manufacturing Plant
businesswire.com — “Press Release Content” View full resource at businesswire.com
Most Recently Shared on March 1, 2012 at 2:29 pm By:
Genzyme Begins Shipping Fabrazyme from Newly Approved Framingham Manufacturing Plant http://t.co/cFdAHOjV
Genzyme Sees End to Fabrazyme Rationing - WSJ.com
online.wsj.com — “Genzyme expects to stop rationing its rare-disease treatment Fabrazyme during the first half of next year, ending a shortage that began in 2009.” View full resource at online.wsj.com
Most Recently Shared on September 15, 2010 at 9:42 pm By:
Genzyme Sees End to Drug's Rationing http://on.wsj.com/d1oxwR
FDA Alert: Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
drugs.com — “FDA Alert: Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen” View full resource at drugs.com
Most Recently Shared on November 14, 2009 at 3:51 am By:
FDA Alert - FDA Warns of Potential for Foreign Particle Contamination in Several Genzyme Products - http://bit.ly/4puEJt
Genzyme Successfully Meets First Milestones of FDA Consent Decree - Drugs.com MedNews
drugs.com — “All Filling and Finishing for U.S. Market Transferred Out of Allston Plant Nov 24, 2010 - Genzyme Corporation (NASDAQ GENZ) announced today that the company has” View full resource at drugs.com
Most Recently Shared on November 24, 2010 at 4:09 pm By:
Drugs and Devices OW OW Health
Genzyme Successfully Meets First Milestones of FDA Consent Decree: All Filling and Finishing for U.S. Mark... http://bit.ly/i9XrVb #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
-
Stéphane Potdevin
Senior Manager Projects New Medias. Pharmaceutical Industry. Interest for Social Media and uses.
-
pharmalot
The latest news and views about the pharmaceutical industry, with Ed Silverman of Pharmalot.com.
Advertisement
